Michael D. Farwell

3.3k citations
51 papers · 1.1k · h-index 17

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • PARP inhibition in cancer therapy
    • Medical Imaging Techniques and Applications
    • Radiomics and Machine Learning in Medical Imaging
    • Radiopharmaceutical Chemistry and Applications

Papers in

    • Cancer Immunotherapy and Biomarkers 19
    • CAR-T cell therapy research 15
    • PARP inhibition in cancer therapy 7
    • Medical Imaging Techniques and Applications 14
    • Radiomics and Machine Learning in Medical Imaging 9
    • Radiopharmaceutical Chemistry and Applications 7

Michael D. Farwell

48 papers receiving 1.1k citations

Peers

Michael D. Farwell
Comparison fields: 5 of 95
  • Oncology 588
  • Radiology, Nuclear Medicine and Imaging 404
  • Cancer Research 138
  • Immunology 160
  • Pulmonary and Respiratory Medicine 207
Replace Matthias Holdhoff with:
Matthias Holdhoff United States
Franziska Eckert Germany
Sridhar Epari India
Jordonna Fulop United States
Rajiv Magge United States
Marcus Unterrainer Germany
MacLean P. Nasrallah United States
Sied Kebir Germany
Weiming Shi United States
Corey Neff United States
Michael D. Farwell relative to Matthias Holdhoff United States Matthias Holdhoff's profile →
Citations per field
00.5×1.5×
Matthias Holdhoff · 1×
Citations per year

Countries citing papers authored by Michael D. Farwell

Since Specialization
Citations

This map shows the geographic impact of Michael D. Farwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Farwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Farwell more than expected).

Fields of papers citing papers by Michael D. Farwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Farwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Farwell. The network helps show where Michael D. Farwell may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael D. Farwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael D. Farwell Line = papers co-authored together Michael D. Farwell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014164
2 2018103
3 202180
4 201680
5 201879
6 201976
7 201660
8 202256
9 202035
10 202234
11 201530
12 201929
13 201925
14 202124
15 202221
16 202020
17 201516
18 201215
19 202114
20 199314

About Michael D. Farwell

Michael D. Farwell is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Immunology and Molecular Biology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), CAR-T cell therapy research (15 papers), Medical Imaging Techniques and Applications (14 papers), Radiomics and Machine Learning in Medical Imaging (9 papers), PARP inhibition in cancer therapy (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Immunotherapy and Immune Responses (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (588 citations), Radiology, Nuclear Medicine and Imaging (404 citations), Cancer Research (138 citations), Immunology (160 citations) and Pulmonary and Respiratory Medicine (207 citations). Michael D. Farwell has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include David A. Mankoff, Daniel A. Pryma, Amy S. Clark, Masanori Ichise, Robert H. Mach, Robert K. Doot, Austin R. Pantel, Mark A. Sellmyer, Catherine Hou and Lilie L. Lin. Their work appears in journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine, JAMA Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact